$8.6301
1.3901[19.20%]
At close: Apr 8
$8.6301
0[0.00%]
After Hours: 5:46PM EDT
Pasithea Therapeutics
(NASDAQ:KTTA)Pasithea Therapeutics Stock (NASDAQ:KTTA), Quotes and News Summary
Pasithea Therapeutics Stock (NASDAQ: KTTA) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 3.891K |
| Day Range | - - - |
| 52 Wk Range | 5.254 - 17.400 |
| Market Cap | $8.996M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 53 |
| Short Interest | 1.11% |
| Days to Cover | 8.45 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Pasithea Therapeutics Corp
Sector
Health Care
Industry
Biotechnology
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Pasithea Therapeutics (KTTA) stock?
You can purchase shares of Pasithea Therapeutics (NASDAQ: KTTA) through any online brokerage.
Who are Pasithea Therapeutics's (KTTA) competitors?
Other companies in Pasithea Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), BioRestorative Therapies (NASDAQ:BRTX), NuCana (NASDAQ:NCNA) and Longeveron (NASDAQ:LGVN).
What is the target price for Pasithea Therapeutics (KTTA) stock?
The latest price target for Pasithea Therapeutics (NASDAQ: KTTA) was reported by EF Hutton on Monday, July 10, 2023. The analyst firm set a price target for 2.00 expecting KTTA to fall to within 12 months (a possible -76.83% downside). 2 analyst firms have reported ratings in the last year.
Current Stock Price for Pasithea Therapeutics (KTTA)?
The stock price for Pasithea Therapeutics (NASDAQ: KTTA) is $8.6301 last updated April 8, 2024 at 5:46 PM EDT.
Does Pasithea Therapeutics (KTTA) pay a dividend?
There are no upcoming dividends for Pasithea Therapeutics.
When is Pasithea Therapeutics (NASDAQ:KTTA) reporting earnings?
Pasithea Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
Is Pasithea Therapeutics (KTTA) going to split?
There is no upcoming split for Pasithea Therapeutics.
What sector and industry does Pasithea Therapeutics (KTTA) operate in?
Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.